• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.NF-κB 诱导激酶维持抗肿瘤免疫中的 T 细胞代谢适应性。
Nat Immunol. 2021 Feb;22(2):193-204. doi: 10.1038/s41590-020-00829-6. Epub 2021 Jan 4.
2
Amino acids and RagD potentiate mTORC1 activation in CD8 T cells to confer antitumor immunity.氨基酸和 RagD 增强 CD8 T 细胞中 mTORC1 的激活以赋予抗肿瘤免疫。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-002137.
3
Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments.在肿瘤微环境中,胸腺中建立的独特代谢程序控制 γδ T 细胞亚群的效应功能。
Nat Immunol. 2021 Feb;22(2):179-192. doi: 10.1038/s41590-020-00848-3. Epub 2021 Jan 18.
4
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.抑制糖酵解代谢可增强 CD8+ T 细胞记忆和抗肿瘤功能。
J Clin Invest. 2013 Oct;123(10):4479-88. doi: 10.1172/JCI69589. Epub 2013 Sep 16.
5
Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.线粒体精氨酸酶-2 是 CD8+T 细胞功能和抗肿瘤疗效的细胞自主调节剂。
JCI Insight. 2019 Nov 21;4(24):132975. doi: 10.1172/jci.insight.132975.
6
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.mTORC1和mTORC2选择性地调节CD8⁺T细胞分化。
J Clin Invest. 2015 May;125(5):2090-108. doi: 10.1172/JCI77746. Epub 2015 Apr 20.
7
Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.TRAF1 在 T 细胞中替代经典 NF-κB 通路的相反作用。
J Biol Chem. 2012 Jun 29;287(27):23010-9. doi: 10.1074/jbc.M112.350538. Epub 2012 May 8.
8
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion.低氧持续刺激诱导的线粒体应激会迅速导致 T 细胞耗竭。
Nat Immunol. 2021 Feb;22(2):205-215. doi: 10.1038/s41590-020-00834-9. Epub 2021 Jan 4.
9
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.DNGR-1 通过限制肿瘤浸润性 I 型常规树突状细胞来限制 Flt3L 介导的抗肿瘤免疫。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002054.
10
Anti-VEGF Treatment Enhances CD8 T-cell Antitumor Activity by Amplifying Hypoxia.抗血管内皮生长因子治疗通过放大缺氧增强 CD8 T 细胞抗肿瘤活性。
Cancer Immunol Res. 2020 Jun;8(6):806-818. doi: 10.1158/2326-6066.CIR-19-0360. Epub 2020 Apr 1.

引用本文的文献

1
Adoptive cell therapy in colorectal cancer: Advances in chimeric antigen receptor T cells.结直肠癌中的过继性细胞疗法:嵌合抗原受体T细胞的进展
World J Gastrointest Oncol. 2025 Jul 15;17(7):106723. doi: 10.4251/wjgo.v17.i7.106723.
2
NF-κB in inflammation and cancer.炎症与癌症中的核因子-κB
Cell Mol Immunol. 2025 Jun 25. doi: 10.1038/s41423-025-01310-w.
3
Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology.二硫化物依赖性细胞程序性坏死的分子特征:与程序性细胞死亡途径的相互作用及其在肿瘤学中的治疗意义
Cell Mol Biol Lett. 2025 Jun 2;30(1):66. doi: 10.1186/s11658-025-00743-5.
4
The NF-κB signaling network in the life of T cells.T细胞生命中的核因子-κB信号网络。
Front Immunol. 2025 Apr 30;16:1559494. doi: 10.3389/fimmu.2025.1559494. eCollection 2025.
5
[High expression of hexokinase 2 promotes proliferation, migration and invasion of colorectal cancer cells by activating the JAK/STAT pathway and regulating tumor immune microenvironment].己糖激酶2高表达通过激活JAK/STAT通路和调节肿瘤免疫微环境促进结肠癌细胞的增殖、迁移和侵袭
Nan Fang Yi Ke Da Xue Xue Bao. 2025 Mar 20;45(3):542-553. doi: 10.12122/j.issn.1673-4254.2025.03.12.
6
RNF2 induces myeloid-derived suppressor cells chemotaxis and promotes hepatocellular carcinoma progression through the TRAF2-NF-κB signaling axis.RNF2通过TRAF2-NF-κB信号轴诱导髓源性抑制细胞趋化并促进肝细胞癌进展。
Cancer Immunol Immunother. 2025 Mar 27;74(5):162. doi: 10.1007/s00262-025-04002-6.
7
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy.小胶质细胞中的葡萄糖代谢重编程:对神经退行性疾病和靶向治疗的意义。
Mol Neurobiol. 2025 Feb 22. doi: 10.1007/s12035-025-04775-y.
8
Development of RelB-targeting small-molecule inhibitors of non-canonical NF-κB signaling with antitumor efficacy.具有抗肿瘤功效的靶向RelB的非经典NF-κB信号小分子抑制剂的研发。
Mol Ther. 2025 Apr 2;33(4):1519-1534. doi: 10.1016/j.ymthe.2025.01.048. Epub 2025 Feb 4.
9
The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers.磷酸戊糖途径:从机制到对胃肠道癌症的影响
Int J Mol Sci. 2025 Jan 13;26(2):610. doi: 10.3390/ijms26020610.
10
UTX Epigenetically Imposes a Cytolytic Effector Program in Autoreactive Stem-like CD8+ T cell Progenitors.UTX通过表观遗传方式在自身反应性干细胞样CD8 + T细胞祖细胞中施加溶细胞效应程序。
bioRxiv. 2024 Dec 20:2024.12.12.628206. doi: 10.1101/2024.12.12.628206.

本文引用的文献

1
Metabolic signaling in T cells.T 细胞中的代谢信号转导。
Cell Res. 2020 Aug;30(8):649-659. doi: 10.1038/s41422-020-0379-5. Epub 2020 Jul 24.
2
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.肿瘤微环境作为效应 T 细胞和免疫疗法的代谢障碍。
Elife. 2020 May 5;9:e55185. doi: 10.7554/eLife.55185.
3
Signaling networks in immunometabolism.免疫代谢中的信号网络。
Cell Res. 2020 Apr;30(4):328-342. doi: 10.1038/s41422-020-0301-1. Epub 2020 Mar 20.
4
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer.G6PD 在细胞生长、细胞死亡和癌症中的氧化还原作用。
Cells. 2019 Sep 8;8(9):1055. doi: 10.3390/cells8091055.
5
The deubiquitinase Otub1 controls the activation of CD8 T cells and NK cells by regulating IL-15-mediated priming.去泛素化酶 Otub1 通过调节 IL-15 介导的启动来控制 CD8 T 细胞和 NK 细胞的激活。
Nat Immunol. 2019 Jul;20(7):879-889. doi: 10.1038/s41590-019-0405-2. Epub 2019 Jun 10.
6
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.探索代谢途径以增强抗肿瘤免疫和免疫治疗。
Nat Rev Clin Oncol. 2019 Jul;16(7):425-441. doi: 10.1038/s41571-019-0203-7.
7
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.慢性病毒感染和癌症中的 CD8 T 细胞耗竭。
Annu Rev Immunol. 2019 Apr 26;37:457-495. doi: 10.1146/annurev-immunol-041015-055318. Epub 2019 Jan 24.
8
Hexokinase 2 is dispensable for T cell-dependent immunity.己糖激酶2对于T细胞依赖性免疫是可有可无的。
Cancer Metab. 2018 Aug 17;6:10. doi: 10.1186/s40170-018-0184-5. eCollection 2018.
9
Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity.代谢重编程调节 T 细胞活性氧生成和抗氧化能力。
Front Immunol. 2018 May 16;9:1075. doi: 10.3389/fimmu.2018.01075. eCollection 2018.
10
Unraveling the Complex Interplay Between T Cell Metabolism and Function.解析 T 细胞代谢与功能之间的复杂相互作用。
Annu Rev Immunol. 2018 Apr 26;36:461-488. doi: 10.1146/annurev-immunol-042617-053019.

NF-κB 诱导激酶维持抗肿瘤免疫中的 T 细胞代谢适应性。

NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.

机构信息

Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

National Creative Research Initiatives Center for Adipose Tissue Remodeling, Department of Biological Sciences, Institute of Molecular Biology and Genetics, Seoul National University, Seoul, Korea.

出版信息

Nat Immunol. 2021 Feb;22(2):193-204. doi: 10.1038/s41590-020-00829-6. Epub 2021 Jan 4.

DOI:10.1038/s41590-020-00829-6
PMID:33398181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7855506/
Abstract

Metabolic reprograming toward aerobic glycolysis is a pivotal mechanism shaping immune responses. Here we show that deficiency in NF-κB-inducing kinase (NIK) impairs glycolysis induction, rendering CD8 effector T cells hypofunctional in the tumor microenvironment. Conversely, ectopic expression of NIK promotes CD8 T cell metabolism and effector function, thereby profoundly enhancing antitumor immunity and improving the efficacy of T cell adoptive therapy. NIK regulates T cell metabolism via a NF-κB-independent mechanism that involves stabilization of hexokinase 2 (HK2), a rate-limiting enzyme of the glycolytic pathway. NIK prevents autophagic degradation of HK2 through controlling cellular reactive oxygen species levels, which in turn involves modulation of glucose-6-phosphate dehydrogenase (G6PD), an enzyme that mediates production of the antioxidant NADPH. We show that the G6PD-NADPH redox system is important for HK2 stability and metabolism in activated T cells. These findings establish NIK as a pivotal regulator of T cell metabolism and highlight a post-translational mechanism of metabolic regulation.

摘要

代谢重编程向有氧糖酵解是塑造免疫反应的关键机制。在这里,我们表明,NF-κB 诱导激酶(NIK)的缺乏会损害糖酵解的诱导,使肿瘤微环境中的 CD8 效应 T 细胞功能低下。相反,NIK 的异位表达促进了 CD8 T 细胞的代谢和效应功能,从而显著增强了抗肿瘤免疫,并提高了 T 细胞过继治疗的疗效。NIK 通过一种不依赖 NF-κB 的机制来调节 T 细胞的代谢,该机制涉及到己糖激酶 2(HK2)的稳定,HK2 是糖酵解途径的限速酶。NIK 通过控制细胞内活性氧水平来防止 HK2 的自噬降解,这反过来又涉及葡萄糖-6-磷酸脱氢酶(G6PD)的调节,G6PD 是一种介导抗氧化剂 NADPH 产生的酶。我们表明,G6PD-NADPH 氧化还原系统对于激活的 T 细胞中 HK2 的稳定性和代谢是重要的。这些发现确立了 NIK 作为 T 细胞代谢的关键调节剂,并强调了代谢调节的一种翻译后机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/09680093d5ba/nihms-1642142-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/528fd4ae85d5/nihms-1642142-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/9816a3b4a1a9/nihms-1642142-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/0e01fbcd2fa5/nihms-1642142-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/f89b8236584f/nihms-1642142-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/3bcbc9204446/nihms-1642142-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/c4668be563c9/nihms-1642142-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/b17209eb9e22/nihms-1642142-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/cf39b3f98e46/nihms-1642142-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/0d06f7efb29f/nihms-1642142-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/483e83dda04c/nihms-1642142-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/864d5f19bf5f/nihms-1642142-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/59ee179d7316/nihms-1642142-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/db38305a1200/nihms-1642142-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/34140e815604/nihms-1642142-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/83558aead3c1/nihms-1642142-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/09680093d5ba/nihms-1642142-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/528fd4ae85d5/nihms-1642142-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/9816a3b4a1a9/nihms-1642142-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/0e01fbcd2fa5/nihms-1642142-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/f89b8236584f/nihms-1642142-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/3bcbc9204446/nihms-1642142-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/c4668be563c9/nihms-1642142-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/b17209eb9e22/nihms-1642142-f0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/cf39b3f98e46/nihms-1642142-f0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/0d06f7efb29f/nihms-1642142-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/483e83dda04c/nihms-1642142-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/864d5f19bf5f/nihms-1642142-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/59ee179d7316/nihms-1642142-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/db38305a1200/nihms-1642142-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/34140e815604/nihms-1642142-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/83558aead3c1/nihms-1642142-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/607a/7855506/09680093d5ba/nihms-1642142-f0008.jpg